The eyonis™ Lung Cancer Screening (LCS) REALITY data – What leading U.S. clinical pulmonology
experts are saying
November 7, 2024
We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology
experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung
cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil
Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from
the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also
will participate and summarize the final REALITY results, which are going to be submitted in
H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.
Global Leader in Central Imaging Services for Oncology Clinical Trials
Median’s best-in-class clinical trial imaging solutions empower sponsors and CROs to
accelerate the development and delivery of life-saving cancer treatments with unmatched
operational excellence and reliability. And we don’t stop there. Median leads the way when
it comes to advanced imaging technology, leveraging the latest innovations in AI-powered
imaging intelligence to supercharge our partners’ drug development strategies.
Our Services
Learn about Median’s clinical trial imaging offering
WHAT WE DO
We are committed to advancing cancer research through imaging. Focused exclusively on
oncology, we deliver unparalleled central imaging services worldwide for phase I-III
studies, ensuring quality in every aspect of our work.
Plus, we are leading the way when it comes to advanced imaging technology. Our Imaging
Lab team of experts leverages the latest in AI/ML to find innovative solutions to our
partners’ most complex drug development challenges.
Core Lab Imaging Services
With 100% dedication to oncology, and proven experience across cancer indications,
therapies, and imaging criteria, we are a trusted partner to manage images in your
next Phase I-III study.
Whether you need centralized, end-to-end, integrated central imaging, or you have a
collect & hold project, you can count on us to deliver imaging excellence.
Median knows the power of advanced technologies when it comes to saving lives. In
addition to our unrivaled core lab imaging services, our Imaging Lab team of experts
leverages the latest in AI/ML to find innovative solutions to our partners’ most
complex drug development challenges.
You can find this team working on projects that have the power to revolutionize our
clients’ oncology programs, from automated QC to early detection of treatment
response.
At Median, we are constantly innovating. We are committed to supporting our partners
with their goals, whether they need help with site selection or general consulting.
The operational and scientific teams you need to support imaging in your next
oncology study
UNMATCHED OPERATIONAL EXCELLENCE
Median’s clinical trial imaging business is comprised of highly responsive, agile, and
customer-centric project teams. Our PMs carry an unprecedentedly low number of projects,
ensuring dedicated attention to your study.
WORLD-CLASS SCIENTIFIC EXPERTISE
Led by Dr. Antoine Iannessi, Head of Medical Affairs at Median
Technologies, our global team of esteemed medical directors and clinical scientists are
dedicated to supporting our clients’ success.
Our Experience
Median is the gold standard for centralized imaging in support of our biopharmaceutical company
partners.
Explore our depth of experience in oncology clinical trials.
270+
Oncology Studies Supported, including 90+ Phase III.
190k+
Image QC’d
3K+
Sites in Our Extensive Site Network
As of 06/30/2024
AI-Powered Imaging Intelligence
We are leading the way when it comes to leveraging advanced technologies in support of
cancer research
Our Imaging Lab team provides new answers in a number of strategic areas that determine the
success of clinical trials, like:
Unlocking AI to include patients with early-stage diseases in relevant clinical trials
Discovering predictive biomarkers of response to drug candidates
Leveraging AI for advanced, intelligent monitoring for in central image reads
And more
Imaging Lab is dedicated to optimizing the clinical development plan for new molecules to
boost the success rate of clinical trials.
Median’s Extensive Clinical Trial Site Network is Made Up of 3K+ Sites Worldwide
Contact us today to learn about how our global site experience can add value to
your study
Gain Access to Our Innovative Clinical Trial Imaging Technology
With iSee®, Median’s proprietary clinical trial imaging software, imaging for
your oncology study runs more smoothly.
iSee® Viewer
Gain expert oversight of clinical trial images with our proprietary, flexible
software that helps identify, quantify, and track lesions across all time points.
Reduce human error and cover a wide range of solid tumors in cancer indications.
Real-time, robust clinical trial image reporting at your fingertips.
From site management, image collection, data management and reads, our reporting
boosts
operational performance, manages risks, and keeps you on top of your study’s imaging
workflow.
Excellent competence, proactiveness and communication skills of the project manager
and team. This is highly appreciated as this study is complex, long, subjected to
frequent adjustments (adaptive design) and involving many stakeholders. We hope to
continue with this dream team. I find especially useful the ORP which I use on a weekly
basis to share information internally and provide metrics.
Project Manager at a
Large Pharmaceutical Company
In my previous experience with imaging vendors, I had issues in establishing the point
of contact and the communication pathways was ineffectual. With the Median team, the
relationship has been developed well and we feel that the Median team understands the
sponsor expectations and steps up to assist when required.
Clinical
Operations Manager at a biopharmaceutical company
Median representatives have been very helpful and responsive to ad-hoc requests for
information and updates. [We] greatly appreciated the collaboration and efforts by the
Median team to meet or exceed our timelines for data cleaning and delivering the most
accurate and real time assessments of scans.
VP of Clinical Operations at
a mid-size pharma company
The Latest from Median’s iCRO Team
BROCHURE
Introducing Median Imaging Lab
Get more value from your oncology trials with transformative
